{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:36:43Z","timestamp":1787593003945,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Health Science and Technology Program of Zhejiang Province of China","award":["2022KY396"],"award-info":[{"award-number":["2022KY396"]}]},{"name":"Health Science and Technology Program of Zhejiang Province of China","award":["2022KY1300"],"award-info":[{"award-number":["2022KY1300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-023-03623-z","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T04:01:43Z","timestamp":1684296103000},"page":"191-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Soluble urokinase plasminogen activator receptor is associated with cardiovascular calcification in peritoneal dialysis patients"],"prefix":"10.1007","volume":"56","author":[{"given":"Jichao","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuli","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuijuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanping","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tujian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"key":"3623_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/jamacardio.2019.0375","volume":"4","author":"ZJ Modi","year":"2019","unstructured":"Modi ZJ, Lu Y, Ji N et al (2019) Risk of cardiovascular disease and mortality in young adults with end-stage renal disease. Jama Cardiol 4:353","journal-title":"Jama Cardiol"},{"key":"3623_CR2","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1080\/0886022X.2022.2100262","volume":"44","author":"J Li","year":"2022","unstructured":"Li J, Li Y, Zou Y et al (2022) Use of the systemic inflammation response index (SIRI) as a novel prognostic marker for patients on peritoneal dialysis. Ren Fail 44:1227\u20131235","journal-title":"Ren Fail"},{"issue":"7","key":"3623_CR3","first-page":"1","volume":"2011","author":"KDIGO","year":"2017","unstructured":"KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2011(7):1\u201359","journal-title":"Kidney Int Suppl"},{"key":"3623_CR4","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1080\/03007995.2018.1467886","volume":"34","author":"ZH Liu","year":"2018","unstructured":"Liu ZH, Yu XQ, Yang JW et al (2018) Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study. Curr Med Res Opin 34:1491\u20131500","journal-title":"Curr Med Res Opin"},{"key":"3623_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/ckj\/sfab174","volume":"15","author":"N Seyahi","year":"2022","unstructured":"Seyahi N, Alagoz S, Atli Z et al (2022) Coronary artery calcification progression and long-term cardiovascular outcomes in renal transplant recipients: an analysis by the joint model. Clin Kidney J 15:101\u2013108","journal-title":"Clin Kidney J"},{"key":"3623_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001118","volume":"3","author":"DJ Eapen","year":"2014","unstructured":"Eapen DJ, Manocha P, Ghasemzadeh N et al (2014) Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events. J Am Heart Assoc 3:e1118","journal-title":"J Am Heart Assoc"},{"key":"3623_CR7","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2215\/CJN.10881016","volume":"12","author":"C Drechsler","year":"2017","unstructured":"Drechsler C, Hayek SS, Wei C et al (2017) Soluble urokinase plasminogen activator receptor and outcomes in patients with diabetes on hemodialysis. Clinical J Am Soc Nephrol 12:1265\u20131273","journal-title":"Clinical J Am Soc Nephrol"},{"key":"3623_CR8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1159\/000489623","volume":"43","author":"W Wu","year":"2018","unstructured":"Wu W, Cui Y, Hu J et al (2018) Soluble urokinase plasminogen activator receptor is associated with coronary artery calcification and cardiovascular disease in patients undergoing hemodialysis. Kidney Blood Press Res 43:664\u2013672","journal-title":"Kidney Blood Press Res"},{"key":"3623_CR9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"3623_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0021-9150(97)00106-8","volume":"132","author":"LI Kauppila","year":"1997","unstructured":"Kauppila LI, Polak JF, Cupples LA et al (1997) New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 132:245\u2013250","journal-title":"Atherosclerosis"},{"key":"3623_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ et al (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827\u2013832","journal-title":"J Am Coll Cardiol"},{"key":"3623_CR12","doi-asserted-by":"crossref","unstructured":"Wlazel RN, Szwabe K, Guligowska A, et al (2020) Soluble urokinase plasminogen activator receptor level in individuals of advanced age. Sci Rep 10","DOI":"10.1038\/s41598-020-72377-w"},{"key":"3623_CR13","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s11255-022-03430-y","volume":"55","author":"J Guan","year":"2023","unstructured":"Guan J, Xie H, Wang H et al (2023) Cardiac valve calcification as a predictor of cardiovascular outcomes in peritoneal dialysis patients: an inverse probability of treatment weighting analysis. Int Urol Nephrol 55:1271\u20131278","journal-title":"Int Urol Nephrol"},{"key":"3623_CR14","doi-asserted-by":"crossref","unstructured":"Hindy G, Tyrrell DJ, Vasbinder A, et al (2022) Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis. J Clin Invest 132","DOI":"10.1172\/JCI158788"},{"key":"3623_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015452","volume":"9","author":"J Nikorowitsch","year":"2020","unstructured":"Nikorowitsch J, Borchardt T, Appelbaum S et al (2020) Cardio-renal biomarker soluble urokinase-type plasminogen activator receptor is associated with cardiovascular death and myocardial infarction in patients with coronary artery disease independent of troponin, C-reactive protein, and renal function. J Am Heart Assoc 9:e15452","journal-title":"J Am Heart Assoc"},{"key":"3623_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017225","volume":"10","author":"JH Jhee","year":"2021","unstructured":"Jhee JH, Nam BY, Lee CJ et al (2021) Soluble urokinase-type plasminogen activator receptor, changes of 24-hour blood pressure, and progression of chronic kidney disease. J Am Heart Assoc 10:e17225","journal-title":"J Am Heart Assoc"},{"key":"3623_CR17","doi-asserted-by":"publisher","first-page":"6927456","DOI":"10.1155\/2019\/6927456","volume":"2019","author":"T Shuai","year":"2019","unstructured":"Shuai T, Yan P, Xiong H et al (2019) Association between soluble urokinase-type plasminogen activator receptor levels and chronic kidney disease: a systematic review and meta-analysis. Biomed Res Int 2019:6927456","journal-title":"Biomed Res Int"},{"key":"3623_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.thromres.2006.03.011","volume":"119","author":"K Pawlak","year":"2007","unstructured":"Pawlak K, Pawlak D, Mysliwiec M (2007) Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity. Thromb Res 119:475\u2013480","journal-title":"Thromb Res"},{"key":"3623_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11255-017-1778-5","volume":"50","author":"RN Wlaze\u0142","year":"2018","unstructured":"Wlaze\u0142 RN, Szadkowska I, Bartnicki P et al (2018) Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients. Int Urol Nephrol 50:339\u2013345","journal-title":"Int Urol Nephrol"},{"key":"3623_CR20","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.ekir.2018.05.004","volume":"3","author":"C Torino","year":"2018","unstructured":"Torino C, Pizzini P, Cutrupi S et al (2018) Soluble urokinase plasminogen activator receptor (suPAR) and all-cause and cardiovascular mortality in diverse hemodialysis patients. Kidney Int Rep 3:1100\u20131109","journal-title":"Kidney Int Rep"},{"key":"3623_CR21","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/j.thromres.2009.08.009","volume":"125","author":"K Pawlak","year":"2010","unstructured":"Pawlak K, Mysliwiec M, Pawlak D (2010) Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients. Thromb Res 125:e40\u2013e45","journal-title":"Thromb Res"},{"key":"3623_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/0394632016689571","volume":"30","author":"M Sun","year":"2017","unstructured":"Sun M, Chang Q, Xin M et al (2017) Endogenous bone morphogenetic protein 2 plays a role in vascular smooth muscle cell calcification induced by interleukin 6 in vitro. Int J Immunopathol Pharmacol 30:227\u2013237","journal-title":"Int J Immunopathol Pharmacol"},{"key":"3623_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.carpath.2017.01.004","volume":"27","author":"K Benz","year":"2017","unstructured":"Benz K, Varga I, Neureiter D et al (2017) Vascular inflammation and media calcification are already present in early stages of chronic kidney disease. Cardiovasc Pathol 27:57\u201367","journal-title":"Cardiovasc Pathol"},{"key":"3623_CR24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ijcard.2012.03.040","volume":"167","author":"S Lyngbaek","year":"2013","unstructured":"Lyngbaek S, Sehestedt T, Marott JL et al (2013) CRP and suPAR are differently related to anthropometry and subclinical organ damage. Int J Cardiol 167:781\u2013785","journal-title":"Int J Cardiol"},{"key":"3623_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2014.08.035","volume":"237","author":"MH Sorensen","year":"2014","unstructured":"Sorensen MH, Gerke O, Eugen-Olsen J et al (2014) Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects. Atherosclerosis 237:60\u201366","journal-title":"Atherosclerosis"},{"key":"3623_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.thromres.2007.10.017","volume":"122","author":"K Pawlak","year":"2008","unstructured":"Pawlak K, Mysliwiec M, Pawlak D (2008) The urokinase-type plasminogen activator\/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients. Thromb Res 122:328\u2013335","journal-title":"Thromb Res"},{"key":"3623_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/path.5193","volume":"247","author":"G S\u00e1nchez Duffhues","year":"2019","unstructured":"S\u00e1nchez Duffhues G, Garc\u00eda De Vinuesa A, van de Pol V et al (2019) Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2. J Pathol 247:333\u2013346","journal-title":"J Pathol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03623-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03623-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03623-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T16:13:24Z","timestamp":1704816804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03623-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["3623"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03623-z","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"assertion":[{"value":"1 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}